These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
535 related articles for article (PubMed ID: 19585717)
1. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks. Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717 [TBL] [Abstract][Full Text] [Related]
2. Cilostazol for intermittent claudication. Bedenis R; Stewart M; Cleanthis M; Robless P; Mikhailidis DP; Stansby G Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003748. PubMed ID: 25358850 [TBL] [Abstract][Full Text] [Related]
3. Cilostazol for intermittent claudication. Brown T; Forster RB; Cleanthis M; Mikhailidis DP; Stansby G; Stewart M Cochrane Database Syst Rev; 2021 Jun; 6(6):CD003748. PubMed ID: 34192807 [TBL] [Abstract][Full Text] [Related]
4. Cilostazol: a review of its use in intermittent claudication. Chapman TM; Goa KL Am J Cardiovasc Drugs; 2003; 3(2):117-38. PubMed ID: 14727939 [TBL] [Abstract][Full Text] [Related]
5. Cilostazol: improving walking distance in patients with intermittent claudication. Collinson DJ; Donnelly R Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):503-9. PubMed ID: 15225110 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication. Lee TM; Su SF; Tsai CH; Lee YT; Wang SS Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048 [TBL] [Abstract][Full Text] [Related]
7. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials. Hood SC; Moher D; Barber GG CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633 [TBL] [Abstract][Full Text] [Related]
8. New treatment options in intermittent claudication: the US experience. Hiatt WR Int J Clin Pract Suppl; 2001 Apr; (119):20-7. PubMed ID: 11355276 [TBL] [Abstract][Full Text] [Related]
9. Cilostazol: treatment of intermittent claudication. Reilly MP; Mohler ER Ann Pharmacother; 2001 Jan; 35(1):48-56. PubMed ID: 11197586 [TBL] [Abstract][Full Text] [Related]
10. A randomized trial of iloprost in patients with intermittent claudication. Creager MA; Pande RL; Hiatt WR Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Thompson PD; Zimet R; Forbes WP; Zhang P Am J Cardiol; 2002 Dec; 90(12):1314-9. PubMed ID: 12480040 [TBL] [Abstract][Full Text] [Related]
12. Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects). Hiatt WR; Money SR; Brass EP J Vasc Surg; 2008 Feb; 47(2):330-336. PubMed ID: 18155871 [TBL] [Abstract][Full Text] [Related]
13. Comparative effects of cilostazol and other therapies for intermittent claudication. Dawson DL Am J Cardiol; 2001 Jun; 87(12A):19D-27D. PubMed ID: 11434896 [TBL] [Abstract][Full Text] [Related]
14. The role of cilostazol (Pletal) in the management of intermittent claudication. Bradbury AW Int J Clin Pract; 2003 Jun; 57(5):405-9. PubMed ID: 12846346 [TBL] [Abstract][Full Text] [Related]